BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12239444)

  • 1. Small cell lung cancer: defining a role for emerging platinum drugs.
    Schiller JH
    Oncology; 2002; 63(2):105-14. PubMed ID: 12239444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
    Jain N; Lam YM; Pym J; Campling BG
    Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
    Sasaki Y; Shinkai T; Eguchi K; Tamura T; Ohe Y; Ohmori T; Saijo N
    Cancer Chemother Pharmacol; 1991; 27(4):263-70. PubMed ID: 1847845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of therapeutic trials of carboplatin in lung cancer.
    Bunn PA
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):27-33. PubMed ID: 2541506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
    Genestreti G; Tiseo M; Kenmotsu H; Kazushige W; Di Battista M; Cavallo G; Carloni F; Bongiovanni A; Burgio MA; Casanova C; Metro G; Scarpi E; Korkmaz T; Selcuk S; Roopa K; Califano R
    Clin Lung Cancer; 2015 Nov; 16(6):e223-8. PubMed ID: 25983005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence based chemotherapy for lung cancer].
    Watanabe H; Saijo N
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):30-43. PubMed ID: 10660731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of carboplatin in the treatment of small-cell lung cancer.
    Ettinger DS
    Oncology (Williston Park); 1998 Jan; 12(1 Suppl 2):36-43. PubMed ID: 9516610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status of clinical trials for small cell lung cancer.
    Fischer B; Arcaro A
    Rev Recent Clin Trials; 2008 Jan; 3(1):40-61. PubMed ID: 18474014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-platinum chemotherapy combined with etoposide in metastatic brain tumor from small cell lung carcinoma.
    Yamada SM; Yamada S; Takahashi H; Teramoto A; Nakayama H
    J Neurooncol; 2005 Feb; 71(3):259-65. PubMed ID: 15735914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum combined with radiation therapy in small cell lung cancer: focusing like a laser beam on crucial issues.
    Turrisi AT
    Semin Oncol; 1994 Jun; 21(3 Suppl 6):36-42. PubMed ID: 8052872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platinum compounds in the treatment of advanced breast cancer.
    Martín M
    Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current standards of care in small-cell and non-small-cell lung cancer.
    Schiller JH
    Oncology; 2001; 61 Suppl 1():3-13. PubMed ID: 11598409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide plus ifosfamide plus cisplatin in the treatment of small cell lung cancer.
    Sandler AB
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):38-41. PubMed ID: 9535210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in chemotherapy for small cell lung cancer: single-agent activity of newer agents.
    Argiris A; Murren JR
    Cancer J; 2001; 7(3):228-35. PubMed ID: 11419031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patients with small-cell lung cancer: from meta-analyses to clinical practice.
    Rossi A; Martelli O; Di Maio M
    Cancer Treat Rev; 2013 Aug; 39(5):498-506. PubMed ID: 23084098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and future prospects for satraplatin, an oral platinum analogue.
    Choy H; Park C; Yao M
    Clin Cancer Res; 2008 Mar; 14(6):1633-8. PubMed ID: 18347164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar chromosomal changes in cisplatin and oxaliplatin-resistant sublines of the H69 SCLC cell line are not associated with platinum resistance.
    Stordal B; Peters G; Davey R
    Genes Chromosomes Cancer; 2006 Dec; 45(12):1094-105. PubMed ID: 16967470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Picoplatin overcomes resistance to cell toxicity in small-cell lung cancer cells previously treated with cisplatin and carboplatin.
    Tang CH; Parham C; Shocron E; McMahon G; Patel N
    Cancer Chemother Pharmacol; 2011 Jun; 67(6):1389-400. PubMed ID: 20809122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experiences with carboplatin (paraplatin) in lung cancer.
    Bunn PA
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):1-11. PubMed ID: 1329216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.